TME PHARM.CONF.IPO EO 1- Working Capital to Net Assets Ratio
TME PHARM.CONF.IPO EO 1- working capital to net assets ratio. TME PHARM.CONF.IPO EO 1- (0N6A) has a Working Capital to Net Assets ratio of 101.1% as of December 2025. Working capital of €-1.60 Million (current assets of €2.12 Million minus current liabilities of €3.72 Million) is measured against net assets of €-1.58 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of TME PHARM.CONF.IPO EO 1- to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of TME PHARM.CONF.IPO EO 1- (2021–2025)
Working capital to net assets ratio of TME PHARM.CONF.IPO EO 1- from 2021 to 2025. This chart shows how TME PHARM.CONF.IPO EO 1-'s Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 101.1%, reflecting working capital of €-1.60 Million against net assets of €-1.58 Million EUR. See defensive interval ratio of TME PHARM.CONF.IPO EO 1- to measure how many days the company can operate on defensive assets alone.
TME PHARM.CONF.IPO EO 1- Working Capital to Net Assets Ratio by Year (2021–2025)
TME PHARM.CONF.IPO EO 1- working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for TME PHARM.CONF.IPO EO 1- from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 0N6A total assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 101.1% | €-1.60 Million | €-1.58 Million | €2.12 Million | €3.72 Million | ▲ +3.7 pp |
| 2024 | 97.3% | €1.57 Million | €1.61 Million | €3.36 Million | €1.79 Million | ▼ -38.4 pp |
| 2023 | 135.7% | €-399.00K | €-294.00K | €2.39 Million | €2.79 Million | ▲ +22.9 pp |
| 2022 | 112.8% | €-1.44 Million | €-1.27 Million | €5.01 Million | €6.45 Million | ▲ +14.5 pp |
| 2021 | 98.3% | €4.43 Million | €4.50 Million | €9.69 Million | €5.27 Million | — |